scholarly journals Determinants of hypertension treatment adherence among a Chinese population using the therapeutic adherence scale for hypertensive patients

Medicine ◽  
2019 ◽  
Vol 98 (27) ◽  
pp. e16116 ◽  
Author(s):  
Jingjing Pan ◽  
Lian Wu ◽  
Huichuan Wang ◽  
Tao Lei ◽  
Bin Hu ◽  
...  
PLoS ONE ◽  
2013 ◽  
Vol 8 (4) ◽  
pp. e62775 ◽  
Author(s):  
Gabrielle K. Y. Lee ◽  
Harry H. X. Wang ◽  
Kirin Q. L. Liu ◽  
Yu Cheung ◽  
Donald E. Morisky ◽  
...  

2020 ◽  
Author(s):  
Selina Graham ◽  
Samantha Neo ◽  
Vivian Auyeung ◽  
John Weinman

Objective: A recent systematic review reported that up to 71% of patients with growth hormone deficiency and their families are non-adherent to treatment as prescribed. Non-adherence to growth hormone treatment presents a substantial and costly problem for the patient, healthcare provider and healthcare system. The current study uniquely investigates the potentially modifiable factors associated with treatment non-adherence in this endocrine disorder. Methods: The cross-sectional study was conducted among 82 parent/caregivers of children with growth hormone deficiency and receiving growth hormone treatment. Self-report questionnaires investigated parents/caregivers’ perceptions and experiences of their child’s condition and prescribed treatment, in addition to their perceived relationship with their healthcare professional. The eight-item Morisky Medication Adherence Scale was used for the assessment of treatment adherence. Results: 62% of parent/caregivers were found to be non-adherent to growth hormone treatment as prescribed. Illness perceptions [consequences, identity and coherence] and treatment concerns were found to be significantly associated with treatment adherence, as was the quality of the healthcare professional-parent/caregiver relationship. Conclusion: The study confirms the extent of the adherence problem evident amongst the paediatric growth hormone deficiency population. In addition, it presents an insight into the explanatory factors that underpin non-adherence to growth hormone treatment. Our findings can be used to inform the development of adherence-focussed interventions, with the purpose to support patients and their families and improve the use of prescribed growth hormone treatment within endocrine clinical practice. Abbreviations: GHD = Growth Hormone Deficiency; rhGH = Recombinant Human Growth Hormone treatment; HCP = Healthcare Professional; MMAS = Morisky Medication Adherence Scale; BIPQ = Brief Illness Perception Questionnaire; BMQ = Beliefs about Medicines Questionnaires-Specific; PHR = Parent-Healthcare Provider Relationship-AIRS© Section II; COM-B = Capability, Opportunity, Motivation – Behavior.


2019 ◽  
Vol 8 ◽  
pp. 204800401989275
Author(s):  
Atsede Getenet ◽  
Mulugeta Tesfa ◽  
Aster Ferede ◽  
Yalew Molla

Introduction Hypertension is a global challenge which accounts for high morbidity and mortality rates in the world. The availability of effective anti-hypertensive medications does not result in a good outcome in controlling blood pressure which points towards poor adherence. Thus, this study was conducted to assess the determinants of adherence to anti-hypertensive medication among hypertensive patients on follow-up in Hawassa Referral Hospital. Methods Institution-based case–control study was conducted on a sample of 289 clients from February to May 2018. Census was conducted on 1600 clients to select cases and controls. Then, systematic random sampling was used to select study subjects, and adherence was measured by Morisky medication adherence scale. The associations of variables were analyzed using bivariable followed by multivariable logistic regression analyses. Results The respondent’s adherence to medication was found to be 67% as measured by Morisky medication adherence scale. The multivariate logistic regression analysis showed that medication adherence was found to be better in younger age (<45) (AOR = 3.8), clients living in urban areas (AOR = 6.84), those clients who had good knowledge (AOR = 3.13), those with no co-morbidities (AOR = 3.14) and patients who controlled their blood pressure (<140/90) (AOR = 2.35). Conclusions The rate of medication adherence was found to be low, and hence educational interventions focusing on factors promoting adherence and patients’ health support should be implemented.


2015 ◽  
Vol 171 ◽  
pp. 1288-1295 ◽  
Author(s):  
Odete Amaral ◽  
Claudia Chaves ◽  
Joao Duarte ◽  
Emilia Coutinho ◽  
Paula Nelas ◽  
...  

Author(s):  
Atileombolo A. Lotika ◽  
Langalibalele H. Mabuza ◽  
Henry I. Okonta

Background: In 2007, a large number of hypertensive patients seen at Natalspruit Hospital had poor adherent to their anti-hypertension treatment which manifested itself through poor blood pressure control. On enquiry, they revealed that they were also taking traditional medicines.Objectives: To explore the reasons given by hypertensive patients for concurrently using traditional and Western medicine.Methods: A qualitative study was conducted amongst nine purposefully selected participants attending treatment at the hospital. Interviews were conducted in the Southern Sotho and IsiZulu languages and were audio-taped. The exploratory question was: ‘Would you tell us why you are taking traditional medicine together with the antihypertensive medicine your arereceiving at this hospital?’ The transcribed and translated transcriptions were analysed using the ‘cut and paste’ method to identify themes.Results: Themes that emerged were that traditional medicine was readily accessible; traditional healers displayed knowledge and confidence in their medicine; traditional medicine was perceived to counteract the side-effects of western medicine; the two streams were perceived to complement each other and both streams could lead to a ‘cure’. Patients were disappointed at the perceived bad attitude of the hospital staff.Conclusion: The reasons given by hypertensive patients for their concurrent use of traditional and Western medicine centred around patients’ relatively favourable perception of traditional medicine and its practitioners. Western medicine health care practitioners should continue health education on antihypertensive medication in a manner acceptable to patients.


2009 ◽  
Vol 105 (2) ◽  
pp. 447-460 ◽  
Author(s):  
Patricia L. Dobkin ◽  
Mirella de Civita ◽  
Sasha Bernatsky ◽  
Aurelio Sita ◽  
Marta Filipski ◽  
...  

The goals of this study were to (1) provide preliminary reliability and validity of the Barriers to Treatment Adherence Questionnaire, developed for patients with fibromyalgia, and (2) examine barriers to adherence and general adherence to multimodal treatment during a 3-mo. period. A secondary goal was to explore in a focus discussion group format patients' perceptions of the adherence process and ways of managing the treatment program. 39 fibromyalgia patients were followed while participating in a combined outpatient program of physiotherapy, occupational therapy, nursing, and cognitive behavioral therapy. The Barriers to Treatment Adherence Questionnaire demonstrated good reliability. Construct validity of the Barriers to Treatment Adherence Questionnaire was supported through significant positive correlations with the General Adherence Scale at Months 1 and 3. In addition, a significant change was observed in scores on the Barriers to Treatment Adherence Questionnaire for the physiotherapy component of treatment, with scores decreasing between Months 2 and 3. Addressing barriers to improve adherence may maximize the benefit of treatment programs.


Author(s):  
Tania Pavão Oliveira Rocha ◽  
José Albuquerque de Figueredo Neto ◽  
Darci Ramos Fernandes ◽  
Ewaldo Eder Carvalho Santana ◽  
Jerusa Emídia Roxo Abreu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document